LYZZ Capital is a venture capital firm in Shanghai that focuses on pharmaceutical, medical, diagnostic and medical service industries. Founded 2015 in Shanghai, China, it invests in series A, series B and venture rounds. Its portfolio companies include Qpex Biopharma, Alpha Biopharma, NewMed Medical, Neurelis, and Chipscreen. As of March 2020, LYZZ Capital has made six investments. Their most recent investment was on October 22, 2018, when Qpex Biopharma raised $33M. Qpex Biopharma, Inc. is a provider of biotechnology services and is based in San Diego, California, United States. LYZZ Capital specializes in seed, early, and expansion stage venture investments.
Kevin Li Ph.D
Founding Managing Partner
Documentaries, videos and podcasts